\
Picardo Silvana Noemi1*, Rodriguez Genta Sergio2, Basilaki Jorge Mario3, Lopreite Gustavo Horacio4, Rey Eduardo5
1Head of Practical Works Chair in Oral and Maxillofacial Surgery II School of Dentistry University of Buenos Aires and Department of Dentistry Favaloro Foundation University Hospital, Argentina
2Head of Practical Works Chair in Oral and Maxillofacial Surgery II School of Dentistry, University of Buenos Aires, Argentina
3Professor of Endodontics Kennedy University School of Dentistry, Former Associate professor of endodontics at the Buenos Aires School of Dentistry, Licensed teacher of the School of Dentistry of the University of Buenos Aires, Vocal Incoming President of the Sociedad De Endodoncia, Argentina
4Associate Professor of Endodontics Kennedy University School of Dentistry, Former Associate professor of endodontics at the Buenos Aires School of Dentistry, Licensed teacher of the School of Dentistry of the University of Buenos Aires, Former President of the Sociedad De Endodoncia, Argentina
5President of the National Academy of Dentistry, Consultant to the National Academy of Medicine, Former Professor of Oral and Maxillofacial Surgery School of Dentistry, University of Buenos Aires, Argentina
*Corresponding author: Picardo Silvana Noemi, Head of Practical Works Chair in Oral and Maxillofacial Surgery II School of Dentistry University of Buenos Aires and Department of Dentistry Favaloro Foundation University Hospital
Submission: September 17, 2020;Published: September 29, 2020
ISSN:2637-7764Volume5 Issue4
The American Surgery of Bone Mineral Research (ASBMR) in 2007 defined MRONJ as “necrotic bone area exposed to the oral environment with more than eight weeks of permanence, in the presence of chronic treatment with BPs, in the absence of radiation therapy to the head and neck”. In 2014 the American Association of Oral and Maxillofacial Surgeons (AAOMS) divided the MRONJ into 4 stages from 0 to 3, according to the clinical and radiological aspect of the osteonecrotic lesion:
Keywords: Osteonecrotic lesion; Dental nerve; Oral-nasal; Endodontic; Bone accumulation; Pathology
Abbreviations: AR: Antiresorptive; BPs: Bisphosphonates; DS: Denosumab; AD: Antiangiogenic Drugs, MRONJ: Medication Related Osteonecrosis of the Jaw; ET: Endodontic Therapy
Antiresorptives (AR): Bisphosphonates (BP), Denosumab (DS) and Antiangiogenic drugs are physician indication in low in cases of Osteoporosis, Paget's Disease, Imperfect Osteogenesis and Fibrous Dysplasia and high concentration to treat Hypercalcemia associated with oncology patients [2].
It is clear from the suggested treatments that before the diagnosis of MRONJ the therapeutic attitude is consolidated in non-invasive maneuvers as endodontic therapy regarding the manipulation of bone tissue, performing the pertinent clinical controls in order to avoid systemic spread to deep planes, due to its pharmacokinetics of bone accumulation that could condition a septicemia picture in affected patients, interacting with the attending physician in the event of a certain event of exacerbation of injuries that affect the patient's general health [3].
Endodontic therapy requires adequate knowledge of the anatomy of the root canal system and its multiple variations [4-7], of the biology and pathology of the dental pulp and periradicular tissues [8]. In turn, the operative procedures require proper disinfection and chemical-mechanical preparation of the root canal, its cleaning and shaping [9-12], and its obturation by means of biocompatible materials that have the ability to stimulate the reparative process [13-15] Tissue repair is an essential process that restores tissue integrity and regular function. However, different therapeutic factors and clinical conditions can interfere in this periapical healing process [16]. This procedure pretends minimize bone injuries in incipient stages MRONJ. It is known respective surgeries are required in case MRONJ stage 3 are consolidated and non-invasive maneuvers could not be effective [1].
At present, a large part of the endodontic treatments performed in the clinic are due to pathologies that refer to the pulp and the periapic. The pulp is a richly vascularized and innervated tissue, delimited by an inextensible environment such as dentin, with terminal blood circulation and a small caliber periapic circulatory access zone. All this means that the defensive capacity of the pulp tissue is very limited against the various aggressions that it may suffer. The pulp tissue can also be affected by a retrograde infection [17], from the periodontal ligament or from the apex during a periodontitis process. Because periapical pathology almost always precedes pulp involvement.
Due to the various causes that produce pulp and periapical pathology, the basic pathogenic process that develops is that of the inflammatory response. The pulp will react causing pulpitis, an inflammation that occurs in response to direct and immune mechanisms. The direct mechanisms are microorganisms, the results reach the pulp through the exposed dentin tubules, either by caries, trauma or irritating factors (bacterial products, bacterias, endotoxins, etc.), which when penetrating through the tubules dentinals, destroy the odontoblast and underlying cells [18]. Complement factors and immunoglobulins act on immune mechanisms.
Endodontic therapy would be providing greater dental therapeutic benefit to compensate for the morbidity of the pathology MRONJ. There is a need not to suspend antiresorptive medication necessary according to medical criteria both in osteoporotic and oncological patients, since in that sense, according to the pharmacokinetics and pharmacodynamics of AR drugs [19,20].
© 2020 Picardo Silvana Noemi. This is an open access article distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and build upon your work non-commercially.